Feinstein Researchers Lead Breakthrough Study for Lupus Kidney Disease In a significant breakthrough for autoimmune disease treatment, researchers at Northwell Health’s Feinstein Institutes for Medical Research have reported encouraging results…
Africa CDC and WHO Revise Mpox Strategy Amid Ongoing Outbreaks In a significant development aimed at containing the ongoing mpox outbreak, the Africa Centres for Disease Control and Prevention (Africa…
Cytokinetics Announces Equity Awards Granted Under Nasdaq Listing Rule 5635(c)(4) Cytokinetics, Incorporated has taken another strategic step in fostering long-term company growth through a robust talent acquisition strategy that includes…
Kairos Pharma Wins DoD Grant to Study ENV105 for Drug-Resistant Lung Cancer Kairos Pharma, Ltd. , a clinical-stage biopharmaceutical company focused on developing novel cancer therapies, has announced a major…
EnPlusOne Biosciences Welcomes New CEO, Clare Murray, Ph.D. EnPlusOne Biosciences, Inc., a trailblazing biotechnology company pioneering enzyme-driven RNA synthesis technologies, announced today the appointment of Clare Murray, Ph.D., as its…
Bruker Launches nVista 2P: A New Generation of Miniature Two-Photon Microscopes Bruker Corporation a global leader in scientific instruments and imaging technologies, has announced the launch of the nVista 2P,…
PharmaJet Highlights Partner Data Showing Enhanced Immune Response with Needle-Free Vaccine Delivery PharmaJet, a medical technology company pioneering innovative approaches to injectable drug delivery, will unveil compelling new data from…
Rigaku Partners with Spera Pharma to Advance Drug Development In a move poised to reshape the landscape of drug discovery and pharmaceutical development, Rigaku Corporation—a leading scientific instrumentation manufacturer—and SPERA…
Glycomine Raises $115M Series C to Advance GLM101 into Phase 2b Trial for PMM2-CDG Glycomine, Inc., a clinical-stage biotechnology company dedicated to developing life-changing therapies for patients suffering from orphan…
EveryONE Medicines Names Michelle L. Mellion, MD, as New Chief Medical Officer EveryONE Medicines, a trailblazing biotech company transforming the way individualized therapies are developed for children suffering from ultra-rare…
Aptar Launches Study to Speed FDA Approval of SmartTrack™ Platform for Inhalers AptarGroup, Inc., a global leader in drug delivery and consumer product dispensing systems, has announced a pivotal step…
Flatiron Health Partners with Veeva to Advance Oncology Research In a significant development for the digital health and clinical research sectors, Flatiron Health—a pioneer in healthtech focused on transforming clinical…
